The Europe Wearable Patch Market is expected to witness market growth of 10.4% CAGR during the forecast period (2020-2026).
Wearable patches are useful for diagnosis and monitoring of chronic diseases. Growing prevalence of diseases like atrial fibrillation has resulted to rise in demand for wearable patches for timely diagnosis. This increasing demand has headed by major players in the market so they are focusing to launch new and technologically advanced and innovative wearable patch.
Moreover, in 2018, L’Oreal and La Roche-Posay has launched ‘My Skin Track UV’ that is a wearable skin and sun safety sensor. This is helpful for the women and men in order to track their personalized exposure to pollution, pollen, UV, and humidity. Many manufacturers are creating their products accessible at affordable price to surge overall sales. The novel development in the wearable skin patches is growing adoption of wearable patches especially in the cosmetic industry.
Rising technological advancement in wearable patches is the main reason for the growth of the market. These patches are used for diagnosis, detection and monitoring of numerous chronic diseases like atrial fibrillation. This, in turn, is growing the demand for wearable patch. Thereby the major players in the market are introducing technologically advanced devices. For example, Philips in May 2020, have received agreement for an advanced disposable wearable sensor patch which can be able to track the heart rate and respiratory rate once the patient is discharged from ICU.
Based on Technology, the market is segmented into Connected Wearable and Regular Wearable. Based on Application, the market is segmented into Non-Clinical and Clinical. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DexCom, Inc., Abbott Laboratories, Koninklijke Philips N.V., Smith & Nephew PLC (Leaf Healthcare, Inc.), Qualcomm, Inc., L'Oreal Group, VivaLNK, Inc., Cardiac Insight, Inc., AliveCor, Inc. and LifeSignals Group, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Technology
By Application
By Country
Companies Profiled
Unique Offerings
Wearable patches are useful for diagnosis and monitoring of chronic diseases. Growing prevalence of diseases like atrial fibrillation has resulted to rise in demand for wearable patches for timely diagnosis. This increasing demand has headed by major players in the market so they are focusing to launch new and technologically advanced and innovative wearable patch.
Moreover, in 2018, L’Oreal and La Roche-Posay has launched ‘My Skin Track UV’ that is a wearable skin and sun safety sensor. This is helpful for the women and men in order to track their personalized exposure to pollution, pollen, UV, and humidity. Many manufacturers are creating their products accessible at affordable price to surge overall sales. The novel development in the wearable skin patches is growing adoption of wearable patches especially in the cosmetic industry.
Rising technological advancement in wearable patches is the main reason for the growth of the market. These patches are used for diagnosis, detection and monitoring of numerous chronic diseases like atrial fibrillation. This, in turn, is growing the demand for wearable patch. Thereby the major players in the market are introducing technologically advanced devices. For example, Philips in May 2020, have received agreement for an advanced disposable wearable sensor patch which can be able to track the heart rate and respiratory rate once the patient is discharged from ICU.
Based on Technology, the market is segmented into Connected Wearable and Regular Wearable. Based on Application, the market is segmented into Non-Clinical and Clinical. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DexCom, Inc., Abbott Laboratories, Koninklijke Philips N.V., Smith & Nephew PLC (Leaf Healthcare, Inc.), Qualcomm, Inc., L'Oreal Group, VivaLNK, Inc., Cardiac Insight, Inc., AliveCor, Inc. and LifeSignals Group, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- Connected Wearable
- Regular Wearable
By Application
- Non-Clinical
- Clinical
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- DexCom, Inc.
- Abbott Laboratories
- Koninklijke Philips N.V.
- Smith & Nephew PLC (Leaf Healthcare, Inc.)
- Qualcomm, Inc.
- L'Oreal Group
- VivaLNK, Inc.
- Cardiac Insight, Inc.
- AliveCor, Inc.
- LifeSignals Group, Inc.
Unique Offerings
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Europe Wearable Patch Market by Technology
Chapter 5. Europe Wearable Patch Market by Application
Chapter 6. Europe Wearable Patch Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- DexCom, Inc.
- Abbott Laboratories
- Koninklijke Philips N.V.
- Smith & Nephew PLC (Leaf Healthcare, Inc.)
- Qualcomm, Inc.
- L'Oreal Group
- VivaLNK, Inc.
- Cardiac Insight, Inc.
- AliveCor, Inc.
- LifeSignals Group, Inc.
Methodology
LOADING...
